Literature DB >> 1362445

Hepatic encephalopathy. Current concepts of the pathogenesis.

J E Maddison1.   

Abstract

Hepatic encephalopathy occurs in a number of different species as a result of either congenital portacaval shunts or acquired liver disease. Despite intensive research, the neurochemical basis of the disorder has not been defined. Theories to explain the cerebral dysfunction that accompanies acute or chronic hepatic failure include 1) ammonia acting as the putative neurotoxin, 2) perturbed monoamine neurotransmission as a result of altered plasma amino acid metabolism, 3) an imbalance between excitatory amino acid neurotransmission, mediated by glutamate, and inhibitory amino acid neurotransmission, mediated by gamma-aminobutyric acid, and 4) increased cerebral concentrations of an endogenous benzodiazepine-like substance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362445     DOI: 10.1111/j.1939-1676.1992.tb00367.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  7 in total

1.  Medical management of a patent ductus venosus in a dog.

Authors:  Timothy S McQuaid
Journal:  Can Vet J       Date:  2005-04       Impact factor: 1.008

2.  Clinical findings and diagnosis in a case of cholangiocellular carcinoma in a horse.

Authors:  M B Conti; M C Marchesi; F Zappulla; D Buttarelli; E Lepri; F Passamonti; S Galletti; G Rucco; F Rueca
Journal:  Vet Res Commun       Date:  2008-09       Impact factor: 2.459

Review 3.  Inherited liver shunts in dogs elucidate pathways regulating embryonic development and clinical disorders of the portal vein.

Authors:  Frank G van Steenbeek; Lindsay van den Bossche; Peter A J Leegwater; Jan Rothuizen
Journal:  Mamm Genome       Date:  2011-11-04       Impact factor: 2.957

4.  Hyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts.

Authors:  Mickey S Tivers; Ian Handel; Adam G Gow; Vicky J Lipscomb; Rajiv Jalan; Richard J Mellanby
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

5.  Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction.

Authors:  Ji Heun Jeong; Do Kyung Kim; Nam-Seob Lee; Young-Gil Jeong; Ho Won Kim; Jong-Seok Kim; Seung-Yun Han
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

6.  Astrocyte lesions in cerebral cortex and cerebellum of dogs with congenital ortosystemic shunting.

Authors:  Alun Williams; Adam Gow; Scott Kilpatrick; Mickey Tivers; Vicky Lipscomb; Ken Smith; Michael Oliver Day; Nick Jeffery; Richard John Mellanby
Journal:  J Vet Sci       Date:  2020-05       Impact factor: 1.672

Review 7.  The cat with neurological manifestations of systemic disease. Key conditions impacting on the CNS.

Authors:  Marc Kent
Journal:  J Feline Med Surg       Date:  2009-05       Impact factor: 2.015

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.